| Bioactivity | Piritrexim isethionate (BW 301U isethionate) is a fat-soluble dihydrofolate reductase inhibitor with activity in the treatment of severe psoriasis. Piritrexim isethionate may be as effective as methotrexate in the treatment of severe psoriasis and may have less hepatotoxicity[1]. |
| CAS | 79483-69-5 |
| Formula | C19H25N5O6S |
| Molar Mass | 451.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. A multicentre 12-week open study of a lipid-soluble folate antagonist, piritrexim in severe psoriasis |
Piritrexim isethionate
CAS: 79483-69-5 F: C19H25N5O6S W: 451.50
Piritrexim isethionate (BW 301U isethionate) is a fat-soluble dihydrofolate reductase inhibitor with activity in the tre
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.